Primary analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma who progressed on or were intolerant to hedgehog inhibitors. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Apr. 19];7(2):s177. Available from: https://skin.dermsquared.com/skin/article/view/2002